Combined percutaneous revascularization and cell therapy after failed repair of anomalous origin of left coronary arteryfrom pulmonary artery

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 6, 2009, Pages 833-837

  de Lezo, José Suárez ^a   Pan, Manuel ^a   Herrera, Concepción ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Coronary stenting; Heart failure; Stem cells

Indexed keywords

ANTICOAGULANT AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACIDOSIS; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW; CARDIOMEGALY; CASE REPORT; CELL THERAPY; CORONARY ARTERY ANOMALY; CORONARY STENT; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOTRACHEAL INTUBATION; FORWARD HEART FAILURE; GASTROINTESTINAL HEMORRHAGE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPONATREMIA; INFANT; INTRACORONARY INFUSION; LABORATORY TEST; LEFT CORONARY ARTERY; LUNG VEIN DRAINAGE ANOMALY; MITRAL VALVE REGURGITATION; MONONUCLEAR CELL; PHYSICAL EXAMINATION; POSTOPERATIVE THROMBOSIS; PULMONARY ARTERY; THORAX RADIOGRAPHY; TREATMENT FAILURE;

ABNORMALITIES, MULTIPLE; AORTOGRAPHY; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY VESSEL ANOMALIES; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HUMANS; INFANT; PULMONARY ARTERY; RECOVERY OF FUNCTION; REPLANTATION; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; STENTS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE; VENTRICULAR FUNCTION, LEFT;

EID: 65549095978     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21891     Document Type: Article

References (24)

1. De Wolf D, Vercruysse T, Suys B, Blom N, Matthys D, Ottenkamp J. Major coronary anomalies in childhood. Eur J Pediatr 2002;161:637-642.
2. Schwartz ML, Jonas RA, Colan SD. Anomalous origin of left coronary artery from pulmonary artery: Recovery of left ventricular function after dual coronary repair. J Am Coll Cardiol 1997;30:547-553.
3. Huddleston CB, Balzer DT, Mendeloff EN. Repair of anomalous left main coronary artery arising from the pulmonary artery in infants: Long-term impact on the mitral valve. Ann Thorac Surg 2001;71:1985-1989.
4. Dodge-Khatami A, Mavroudis C, Backer CL. Anomalous origin of the left coronary artery from the pulmonary artery: Collective review of surgical therapy. Ann Thorac Surg 2002;74:946-955.
5. Barth MJ, Allen BS, Gulecyuz M, Chiemmongkoltip P, Cuneo B, Ilbawi MN. Experience with an alternative technique for the management of anomalous left coronary artery from the pulmonary artery. Ann Thorac Surg 2003;76:1429-1434.
6. Di Salvo G, Eyskens B, Claus P, D'hooge J, Bijnens B, Suys B, De Wolf D, Gewillig M, Sutherland GR, Mertens L. Late post-repair ventricular function in patients with origin of the left main coronary artery from the pulmonary trunk. Am J Cardiol 2004;93:506-508.
7. Chrysant GS, Balzer D, Taniuchi M. Left main stem coronary artery stenting in a 3-month-old child after anomalous left coronary artery from pulmonary artery repair. Pediatr Cardiol 2005;26:734-736.
8. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cells transplantation in humans. Circulation 2002;106:1913-1918.
9. Assmus B, Schaüchinger V, Teupe C, Britten M, Lehmann R, Doübert N, Gruündwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation 2002;106:3009-3017.
10. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, Zeiher AM. Infarct remodeling after intracoroanary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-2218.
11. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomized controlled clinical trial. Lancet 2004;364:141-148.
12. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Peñarrubia MJ, de la Fuente L, Gomez-Bueno M, Cantalapiedra A, Fernandez J, Gutierrez O, Sanchez PL, Hernandez C, Sanz R, Garcia-Sancho J, Sanchez A. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004;95:742-748.
13. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004;44:1690-1699.
14. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 2006; 367:113-121.
15. Schächinger V, Erbs S, Elsäser A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
16. Schächinger V, Erbs S, Elsäser A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Asmus B, Tonn T, Dimmeler S, Zeiher AM. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006;27:2775-2783.
17. Erbs S, Linke A, Schächinger V, Assmus B, Thiele H, Diederich KW, Hoffmann C, Dimmeler S, Tonn T, Hambrecht R, Zeiher AM, Schuler G. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: The Doppler Substudy of the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 2007; 116:366-374.
18. Suárez de Lezo J, Herrera C, Pan M, Romero M, Pavlovic D, Segura J, Sanchez J, Ojeda S, Torres A. Regenerative therapy in patients with revascularized acute anterior myocardial infarction and depressed ventricular function. Rev Esp Cardiol 2007;60: 346-348.
19. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008;102:1319-1330.
20. Turan RG, Brehm M, Koestering M, Tobias Z, Bartsch T, Steiner S, Picard F, Ebner P, Schannwell CM, Strauer BE. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Eur J Clin Invest 2007;37:842-851.
21. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, Bastidas N, Aarabi S, Chan DA, Freedman ML, Giaccia AJ, Gurtner GC. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 2007;116:2818-2829.
22. Roobrouk VD, Ulloa-Montoya F, Verfaille CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 2008;314:1937-1944.
23. Chamber SM, Goodell MA. Hematopoietic stem cell aging: Wrinkles in stem cell potential. Stem Cell Rev 2007;3:201-211.
24. Beauséjour C. Bone marrow-derived cells: The influence of aging and cellular senescence. Handb Exp Pharmacol 2007;180: 67-88.